论文部分内容阅读
目的探讨改良提上睑肌缩短术治疗重度先天性上睑下垂的临床效果。方法对38例先天性上睑下垂患者进行改良提上睑肌缩短手术,观察术后疗效。结果正矫30眼(79%),欠矫7眼(18%),复发1眼(3%)、复发者为3岁患儿,无过矫病例。大部分患者均能在3个月内自然闭合眼睑,最迟者为1年。随访时间半年~1年,无一例发生暴露性角膜溃疡。结论改良提上睑肌缩短术治疗重度先天性上睑下垂安全、可靠,是一种实用的治疗手段。
Objective To investigate the clinical effect of modified levator muscle shortening on severe congenital blepharoptosis. Methods 38 patients with congenital blepharoptosis were treated with levator muscle shortening and the curative effect was observed. Results Correction of 30 eyes (79%), undercorrection of 7 eyes (18%), recurrence of 1 eye (3%), recurrence of 3 years old children, no overcorrection cases. Most patients are able to naturally close the eyelid within 3 months, the latest one year. Follow-up time of six months to 1 year, no case of corneal ulceration occurred. Conclusion It is safe and reliable to treat the severe congenital blepharoptosis with improved levator muscle shortening. It is a practical treatment.